Skip to ContentSkip to Navigation
founded in 1614  -  top 100 university
About us Practical matters How to find us J.F. Ubbels

Publications

Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: The Phase 2 DOREMY Nonrandomized Clinical Trial

Radiotherapy Response Prediction in Myxofibrosarcomas and Undifferentiated Soft Tissue Sarcomas Using DNA Methylation and Copy Number Profiling

Pandemic driven preoperative moderate hypofractionated radiotherapy for soft tissue sarcomas

Recovery of quality of life in 574 patients with inoperable lung cancer undergoing (chemo)radiotherapy

Reducing ΔNTCP by improving proton radiotherapy planning in advanced stage non-small cell lung cancer (NSCLC) patients

Repeat SABR likely required for survival benefit in oligometastatic colorectal cancer: results from the prospective randomised SABR-SCAN trial

Rising incidence of radiation pneumonitis after adjuvant durvalumab in NSCLC patients treated with concurrent chemoradiotherapy

STRONG II trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma – a single-arm multicentre phase II study

Baseline Blood CD8+ T Cell Activation Potency Discriminates Responders from Non-Responders to Immune Checkpoint Inhibition Combined with Stereotactic Radiotherapy in Non-Small-Cell Lung Cancer

Metastases-directed local therapies (MDT) beyond genuine oligometastatic disease (OMD): Indications, endpoints and the role of imaging

Sustainable Development Goals

SDG 3 - Good Health and Well-being

More information about the Sustainable Development Goals.